Pulsed release of antidepressants from nanocomposite hydrogels
暂无分享,去创建一个
[1] M. Casolaro,et al. Polyelectrolyte Hydrogel Platforms for the Delivery of Antidepressant Drugs , 2016, Gels.
[2] M. Casolaro,et al. Stimuli-Responsive Hydrogels Bearing ñamino acid Residues: a PotentialPlatform for Future Therapies , 2016 .
[3] M. Casolaro,et al. Controlled release of antidepressant drugs by multiple stimuli-sensitive hydrogels based on α-aminoacid residues , 2015 .
[4] T. Hoare,et al. Enhanced Pulsatile Drug Release from Injectable Magnetic Hydrogels with Embedded Thermosensitive Microgels. , 2015, ACS macro letters.
[5] M. Casolaro,et al. Long-term doxorubicin release from multiple stimuli-responsive hydrogels based on α-amino-acid residues. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] B. Baltes,et al. The Efficacy of Paroxetine and Placebo in Treating Anxiety and Depression: A Meta-Analysis of Change on the Hamilton Rating Scales , 2014, PloS one.
[7] C. Katona,et al. New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder , 2014, Neuropsychiatric disease and treatment.
[8] M. Casolaro,et al. CHAPTER 20:Multiple Stimuli-responsive Hydrogels Based on α-Amino Acid Residues for Drug Delivery , 2013 .
[9] R. Barbucci,et al. Biohydrogels with magnetic nanoparticles as crosslinker: characteristics and potential use for controlled antitumor drug-delivery. , 2012, Acta biomaterialia.
[10] D. Baldwin,et al. Vortioxetine (Lu AA21004) in the long-term open-label treatment of major depressive disorder , 2012, Current medical research and opinion.
[11] Stefania Lamponi,et al. Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[12] M. Casolaro,et al. Multiple Stimuli-Responsive Hydrogels for Metal-Based Drug Therapy , 2012 .
[13] Ellen Frank,et al. Major depressive disorder: new clinical, neurobiological, and treatment perspectives , 2012, The Lancet.
[14] M. Casolaro,et al. Hydrogel containing L-valine residues as a platform for cisplatin chemotherapy. , 2011, Colloids and surfaces. B, Biointerfaces.
[15] R. Bergstrom,et al. Duloxetine: clinical pharmacokinetics and drug interactions. , 2011, Clinical pharmacokinetics.
[16] S. Ohdo. Chrono-drug-delivery focused on biological clock: intra- and inter-individual variability of molecular clock. , 2010, Advanced drug delivery reviews.
[17] Yu Zhang,et al. Magnetically Sensitive Alginate-Templated Polyelectrolyte Multilayer Microcapsules for Controlled Release of Doxorubicin , 2010 .
[18] M. Casolaro,et al. Cisplatin/hydrogel complex in cancer therapy. , 2009, Biomacromolecules.
[19] Smriti Iyengar,et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. , 2005, Pain medicine.
[20] E. Paccagnini,et al. Stimuli-Responsive Polymers Based on l-Phenylalanine Residues: Protonation Thermodynamics of Free Polymers and Cross-Linked Hydrogels , 2005 .
[21] Zonghuan Lu,et al. Magnetic switch of permeability for polyelectrolyte microcapsules embedded with Co@Au nanoparticles. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[22] M. Casolaro,et al. Vinyl polymers based on L-histidine residues. Part 1. The thermodynamics of poly(ampholyte)s in the free and in the cross-linked gel form. , 2004, Biomacromolecules.
[23] Nicholas A Peppas,et al. Stimuli-sensitive hydrogels: ideal carriers for chronobiology and chronotherapy , 2004, Journal of biomaterials science. Polymer edition.
[24] Teruo Okano,et al. Pulsatile drug release control using hydrogels. , 2002, Advanced drug delivery reviews.
[25] Alan D. Lopez,et al. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.
[26] Nikolaos A. Peppas,et al. Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels , 1996 .
[27] M. Casolaro. Vinyl Polymers Containing L-Valine and L-Leucine Residues: Thermodynamic Behavior of Homopolymers and Copolymers with N-Isopropylacrylamide , 1995 .
[28] C. Nemeroff. The Clinical Pharmacology and Use of Paroxetine, a New Selective Serotonin Reuptake Inhibitor , 1994, Pharmacotherapy.
[29] Yoshihiro Ito,et al. An insulin-releasing system that is responsive to glucose , 1989 .
[30] C. Buhusi,et al. MENTAL DISORDERS , 1969 .
[31] F. Artigas,et al. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. , 2015, Pharmacology & therapeutics.
[32] Praveen Khirwadkar,et al. CHRONOPHARMACOTHERAPY: A NIGHT TIME THERAPY , 2011 .
[33] Dean-Mo Liu,et al. Magnetic-sensitive silica nanospheres for controlled drug release. , 2008, Langmuir : the ACS journal of surfaces and colloids.